Walker Neal
- SEC CIK
- 0001604457
No open-market purchases or sales filed in the past year.
Current role at each company
- ALDX Aldeyra Therapeutics, Inc.Directoras of Jun 11, 2026
- ACRS Aclaris Therapeutics, Inc.CEOas of Feb 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Walker Neal as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACRS Aclaris Therapeutics, Inc.
CEO6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2022 (view filing) | Feb 9 | 2 days | Walker NealPresident and CEO | SSale | −3.60K | $12.66 | −$45.5K | −0.3%1.24M after | |
| Mar 14, 2022 (view filing) | Mar 11 | 3 days | Walker NealPresident and CEO | SSale | −56.3K | $15.91 | −$895.8K | −4.1%1.32M after | |
| Apr 25, 2022 (view filing) | Apr 21-25 | 4 days | Walker NealPresident and CEO | SSale | −70.0K | $15.15 | −$1.06M | −5.3%1.25M after | 3 lots |
| Jan 4, 2023 (view filing) | Jan 3-4 | 1 day | Walker NealDirector | SSale | −40.0K | $15.12 | −$604.7K | −3.2%1.21M after | 3 lots |
| Feb 3, 2023 (view filing) | Feb 1-2 | 2 days | Walker NealDirector | SSale | −30.0K | $16.67 | −$500.0K | −2.5%1.18M after | 5 lots |
| Mar 3, 2023 (view filing) | Mar 2-3 | 1 day | Walker NealDirector | SSale | −59.2K | $12.50 | −$740.7K | −4.4%1.27M after | 2 lots |